Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
28.80
+0.08 (0.28%)
May 21, 2025, 12:50 PM - Market open
Claritev Market Cap
Claritev has a market cap or net worth of $473.37 million as of May 21, 2025. Its market cap has increased by 10.33% in one year.
Market Cap
473.37M
Enterprise Value
5.08B
1-Year Change
10.33%
Ranking
Category
Stock Price
$28.80
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $473.37M, an increase of 94.80%. That is a compound annual growth rate of 13.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 472.05M | 97.50% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.73B |
| Johnson & Johnson | 369.28B |
| AbbVie | 325.69B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 290.91B |
| Abbott Laboratories | 235.14B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |